For the last three years, the BioPhorum Viral Clearance team have completed a short survey on their published papers to understand how they have been used and the response of regulators if used to support filings. This is the report for 2022
Viewing related articles
Viral Clearance worst-case conditions presentation at PDA Viral Clearance conference
Jun 2022 | Conference, Deliverable, Deliverables Report, Development Group, Viral Clearance
This member only resource developed by the BioPhorum Development Group Viral Clearance team is based on their analysis of the worst-case conditions benchmarking survey and was presented at the PDA Viral Clearance conference in Brussels in June 2022.
Modular Viral Clearance for IND filing benchmarking survey
Oct 2021 | Benchmarking, Deliverables Report, Development Group, Viral Clearance
A benchmarking survey on the experiences in applying prior knowledge and modular claims to health authority regulatory submission for clinical programs and licensure applications.
Viral Clearance worst-case conditions presentation
Oct 2021 | Conference, Development Group, Viral Clearance
Poster presentation at BPI East based on analysis of the Viral Clearance worst-case conditions benchmarking survey.
Viral Clearance worst-case conditions benchmarking survey review and analysis
Oct 2021 | Benchmarking, Development Group, Viral Clearance
A benchmarking survey looking at worse-case conditions, which is contributing to a paper that the team are currently writing.